Emerging Roles of Non-Coding RNAs in Childhood Asthma

Abstract

Asthma is a chronic airway inflammatory disease in children characterized by airway inflammation, airway hyperresponsiveness and airway remodeling. Childhood asthma is usually associated with allergy and atopy, unlike adult asthma, which is commonly associated with obesity, smoking, etc. The pathogenesis and diagnosis of childhood asthma also remains more challenging than adult asthma, such as many diseases showing similar symptoms may coexist and be confused with asthma. In terms of the treatment, although most childhood asthma can potentially be self-managed and controlled with drugs, approximately 5–10% of children suffer from severe uncontrolled asthma, which carries significant health and socioeconomic burdens. Therefore, it is necessary to explore the pathogenesis of childhood asthma from a new perspective. Studies have revealed that non-coding RNAs (ncRNAs) are involved in the regulation of respiratory diseases. In addition, altered expression of ncRNAs in blood, and in condensate of sputum or exhalation affects the progression of asthma via regulating immune response. In this review, we outline the regulation and pathogenesis of asthma and summarize the role of ncRNAs in childhood asthma. We also hold promise that ncRNAs may be used for the development of biomarkers and support a new therapeutic strategy for childhood asthma.

Introduction

Asthma is one of the most common chronic inflammatory disease characterized by high heterogeneity in pathogenesis (Koczulla et al., 2017; Papi et al., 2018), with symptoms including showing paroxysmal, reversible wheezing, shortness of breath, chest tightness and cough, which occur or intensify at night and/or in the early morning (Holgate et al., 2015). With the exposure of allergens and the use of antibiotics in the first year of infant life, the prevalence of asthma in children is rising (Metsälä et al., 2015). According to the data from the Centers for Disease Control and Prevention (CDC) in 2016, the prevalence of asthma in children aged 5–11 and 12–17 is respectively 9.6% and 10.5% (Haktanir Abul and Phipatanakul, 2019).

Asthma affects more than nearly 339 million people globally from childhood to old age, among which childhood asthma is more complicated than adult asthma with multiple phenotypes and variable natural course (Lambrecht and Hammad, 2015; Jat and Kabra, 2017; Qiu et al., 2019; El-Husseini et al., 2020). Evidences confirm that childhood asthma is associated with allergy and strongly driven by genetic and environmental factors which determine the susceptibility and severity of asthma (Lee et al., 2017; Tang et al., 2018a). The typical feature of childhood asthma is airway hyper-responsiveness (AHR), Th2-driven eosinophilic airway inflammation and airway remodeling (Qiu et al., 2019; Li et al., 2021). As for adult asthma, it not only shares the same features with childhood asthma, but also is strongly associated with smoking, obesity, and occupational exposures (Kirenga et al., 2020), which mainly refers to non-Th2-type asthma. Different from adult asthma, childhood asthma is usually related to environmental allergens, such as IgE-dependent Th2-type allergic reaction and viral infections and so on (Ferreira et al., 2019; Qiu et al., 2019; Hammad and Lambrecht, 2021). The onset of childhood asthma involves eosinophils, mast cells, T lymphocytes, neutrophils, airway epithelial cells and their cellular components, leading to increased airway responsiveness, and ultimately resulting in widespread and variable reversible airflow limitation (Foster et al., 2017) (Figure 1).

FIGURE 1

Airway remodeling mainly refers to a constellation of structural changes induced by asthma, including epithelial injury, increased thickness of the basement membrane, airway angiogenesis and so on (Enomoto et al., 2009; Inoue et al., 2020). Additionally, studies confirm that vascular endothelial growth factor (VEGF), an important mediator in airway structural changes, has a proliferation-inducing effect on normal bronchial epithelial cells and bronchial smooth muscle cells and is increased in children with recurrent early wheezing (Yoshisue et al., 2007; Enomoto et al., 2009). The upregulation of VEGF and downregulation of lymphocyte lead to the development of airway remodeling in asthma (Altman et al., 2019). At present, asthma predictive index is used to judge childhood asthma with wheezing combined with clinical experience at home and abroad, but the diagnosis of asthma in children under 6 years old is still a challenging clinical problem (Lee et al., 2019a; Driscoll et al., 2020). Underdiagnosis of asthma leads to delays in the optimal timing of asthma treatment and may prompt the transition from mild asthma to severe, refractory asthma (Shi et al., 2020). Although the efficacy of pharmacotherapies including inhaled corticosteroids and leukotriene receptor antagonists may help prevent airway remodeling, they cannot reverse the established airway remodeling (Huo et al., 2021). Consequently, it is necessary to strengthen the understanding of the pathogenesis of childhood asthma in order to improve early diagnosis rate. Meanwhile, intervention in the occurrence of airway remodeling is crucial to preventing and treating asthma in children.

NcRNAs are non-protein-coding RNAs molecules, mainly including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), which are profoundly involved in post-transcriptional gene expression and participate in the regulation of various biological processes (Defnet et al., 2019; Zangouei et al., 2020; Wang et al., 2021). Some studies have confirmed that ncRNAs play a crucial role in the pathogenesis and regulation of asthma including childhood asthma and adult asthma (Qiu et al., 2018; Yang et al., 2022). Correctly, miRNAs are involved in the regulation of airway inflammation and airway smooth muscle proliferation. LncRNAs not only regulate airway inflammation and airway remodeling, but also affect the regulation of immune responses (Narożna et al., 2017; Elnady et al., 2020; Dai et al., 2021). Moreover, emerging evidence implicates that circRNAs are also involved in the proliferation of smooth muscles and airway remodeling in the progression of asthma (Jiang et al., 2021; Wasti et al., 2021). Hence, ncRNAs are considered as potential biomarkers and promising therapeutic targets for childhood asthma (Narożna et al., 2017; Specjalski and Jassem, 2019).

Clinically, children are special categories of patients and childhood asthma can be misdiagnosed as other diseases with similar symptoms (Abdullahi et al., 2016), which makes the diagnosis of asthma difficult. Besides, even if most childhood asthma patients are relieved after treatment in the early stages according to the international recommendations of the Global Asthma Initiative, drug failure and drug resistance often occur during asthma treatment. That’s to say, up to 5%–10% of children have severe asthma or poor asthma control (Moral et al., 2021; Ntontsi et al., 2021). Therefore, further understanding of the pathogenesis of asthma, especially the identification of differential pathogenesis of asthma between children and adults, will help to find the way of more effective diagnoses and treatments. Accordingly, mechanism study of ncRNAs on the pathogenesis of childhood asthma is worthy of attention. In this review, we mainly demonstrate the pathogenesis of childhood asthma and emerge roles of ncRNAs in asthma. Besides, we hold great promise for the discovery of new ncRNAs biomarkers and therapeutics for asthma.

Asthma-Associated Pathogenesis

Immune Factors in the Development and Regulation of Childhood Asthma

Asthma is a heterogenous disease with complex pathogenesis and various phenotypes which can be reclassified via molecular biomarkers called “endotypes” (Bond et al., 2018; Assaf and Hanania, 2019). At present, asthma endotypes are divided into T-helper-2(Th2)-high (eosinophilic) and Th2-low (non-eosinophilic). The ratio tilt of T lymphocyte subsets (Th1/Th2) is the most important pathogenesis of asthma (Tang et al., 2018b). Th2-high asthma is related to adaptive immunity and allergic asthma (Lampalo et al., 2019; Song et al., 2019). Upon allergens stimulation, dendritic cells (DCs) activate T-helper-2 (Th2) cells to secrete Th2 cytokines such as IL-4, IL-5 and IL-13 which act on airway epithelial cells, eosinophils, B lymphocytes and other inflammatory cells. This drives B cells to produce a large number of IgE that cross-linking causes degranulation of mast cells to produce a series of inflammatory mediators such as leukotrienes, endothelin, prostaglandin and thromboxane A2, etc. and eventually induce rapid onset (increased IgE) allergies and eosinophilic airway inflammation (Bégin and Nadeau, 2014; Chogtu et al., 2016; McCracken et al., 2016). Studies have shown that childhood asthma is associated with eosinophils in the airways, allergic sensitization and adaptive immunity (Kim et al., 2010). Th2 cells concretely activated by allergens via secreting Th2 cytokines IL-4, IL-5 and IL-13, amplify type II inflammation, while T helper 1 (Th1) cells by secreting Th1 cytokines such as IFN-γ, IL-2, lymphotoxin (LT)-α and tumor necrosis factor (TNF)-α and so on, limit type II inflammation and mediate type I inflammation (Foster et al., 2017; Mukherjee and Nair, 2018), which causing childhood asthma. Consequently, the imbalance of the ratio of T lymphocyte subsets (Th1/Th2) is the key mechanism of childhood asthma, whether it is innate immunity or adaptive immunity.

However, non-Th2-type asthma related to non-allergic asthma, which is characterized by emotion, obesity, environmental factors, such as air pollution including ozone, cigarette smoke and so on, may release cytokines such as Il-17 and IFN-γ by activation of Th1 cells, leading to neutrophilic inflammation, M1 macrophage, NKT cell recruitment to the airways and AHRs (Castan et al., 2020; Agache et al., 2021). Nevertheless, non-Th2-type asthma characterized by type I innate lymphoid cells (ILC1) and type III innate lymphoid cells activation (ILC3) is most common in adult asthma. ILC1 in asthma patients promoted eosinophil apoptosis and inhibited eosinophilic airway inflammation (Barnig et al., 2013; Barnig and Levy, 2015). ILC3 produced IL-17A and caused obesity-related AHR effects (Kim et al., 2014). Furthermore, other cytokines (such as IL-17, IL-21, IL-22) also accelerated mucus secretion of airway smooth muscle cells, increased the production of cytokines and chemokines, and promoted neutrophil recruitment by inducing CXC chemokines (Lejeune et al., 2020). In addition, IL-17 promoted airway remodeling by increasing the production of fibrotic cytokines, angiogenic factors, proteases and collagen.

Moreover, airway epithelial cells and type II innate lymphoid cells (ILC2) are also involved in adaptive immune. After allergens exposure, epithelial cells polarize macrophages, DC cells, T cells, etc. (Frati et al., 2018; Lejeune et al., 2020), releasing not only IL-4, IL-5, IL-13 and other cytokines but also pro-inflammatory cytokines such as IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) activating ILC2 rather than IFN-γ and TNF-β produced by Th1 cells (Lejeune et al., 2020), which causes Th0 cells polarized into Th2 cells in asthma-specific cytokine environments, resulting in a balanced skewed Th2 cellular immune response. The immune response of Th2 cells further induced changes in the pathophysiological characteristics of asthma, including eosinophils mobilizing IgE, secreting excessive mucus, smooth muscle proliferation and airflow obstruction. Additionally, under the effect of IL-5, eosinophils entered the respiratory tract and triggered a second inflammatory response (Deschildre et al., 2017; Gao et al., 2017). Studies have shown that CD4⁺ T cells are essential for inducing allergic airway disease in newborns, and ILC2s are very important in the pathogenesis of allergic airway disease in adults. Mechanistically, CD4⁺ T cells and ILC2s regulate asthma by promoting the production of IL-13 amplifying type II inflammation (Saglani et al., 2018) (Figure 2). Therefore, understanding the role of immune factors in the development and regulation of asthma will provide opportunities for asthma treatment.

FIGURE 2

Mitogen-Activated Protein Kinase Signaling Pathways Involved in Childhood Asthma

Neural signaling pathway also has appealing potential as an application to study pathways to childhood asthma development. Molecular studies have indicated that Mitogen-activated protein kinase (MAPK) pathways, including extracellular signal-regulated kinase 1/2 (ERK1/2), p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase (JNK), are involved in the inflammatory response and development of airway remodeling during childhood asthma (Lee et al., 2019b; Jia et al., 2019). Concretely, ERK1/2 is involved in airway remodeling (Defnet et al., 2019), while p38 MAPK and JNK are considered as anti-inflammation targets to regulate inflammatory processes via phosphorylation of downstream mediators in childhood asthma (Kim and Choi, 2010; Pulido and Lang, 2019; Theodorou et al., 2022). However, literatures about the pathogenesis of MAPK pathways in childhood asthma are limited. In this review we mainly focus on the roles of MAPK signaling pathways in the pathogenesis and related treatment of childhood asthma.

Experiment shows ERK1/2 signaling mainly acts on airway epithelial cells and smooth muscle cells of asthmatic mice (Liu et al., 2008). Concretely, ERK1/2 inducible proteins Jun b proto-oncogene (JunB) mediates ERK1/2 activation via the AP-1 complex, which increases the expression of several Th2 cytokines and drives Th2 cell differentiation, causing childhood asthma (Alam and Gorska, 2011). Besides, sprouty-2, a cytosolic adapter protein, also regulates receptor-mediated ERK1/2 activation by preventing c-Cbl-mediated degradation of EGF receptor, which also stimulates Th2 cell differentiation to amplify Th2 inflammation (Liu et al., 2008; Alam and Gorska, 2011; Sripada et al., 2021). However, further mechanism about ERK1/2 in childhood asthma is needed to explore.

In contrast to ERK1/2, p38 MAPKs and the JNK pathways favor Th1 differentiation. P38 MAPK and JNK activation contributes to the inflammatory response in asthma. Moreover, p38 MAPK is observed in the basal layer of the columnar epithelium, alveolar macrophage and bronchial epithelial, ect. driving basal metabolic processes for these cell type. That’s to say, p38 MAPK is vital for allergen induced epithelial production of IL-25 and thymic stromal lymphopoietin (TSLP), further mediating the type-2 allergic response in asthma (Yu et al., 2010; Lin et al., 2015; Southworth et al., 2018). Previous studies have confirmed that dual-specificity phosphatase1 (DUSP1) also plays vital role in anti-inflammation by deactivating MAPKs through dephosphorylation (Pulido and Lang, 2019; Xin et al., 2021; Theodorou et al., 2022; Xing and Wong, 2022). Besides, Studies have confirmed that JNK is essential for airway inflammation via modulating RAGE/β-catenin signaling (Huang et al., 2021a). Regretfully, further mechanisms between JNK and RAGE/β-catenin is deserved exploring (Figure 3).

FIGURE 3

Genetic Susceptibility of Childhood Asthma

Although the immune mechanisms and signaling pathways of asthma are widely reported, complex interactions between genetic susceptibility and environmental influences also lead to childhood asthma (Thomsen, 2015). Studies have shown that the genetic susceptibility of asthma can be as high as 60–70%, which suggests that understanding the genetic basis of childhood asthma might unravel mechanisms, directing the treatment of asthma. So further genome-wide association studies (GWAS) is imminent due to the complexity and heterogeneity of asthma (Alizadeh et al., 2017; Kabesch and Tost, 2020). Consequently, it has been found that the main genetic risk factor for asthma is single nucleotide polymorphism (SNPs), which is a single-base pair, occurring on average one in 300 nucleotides (Lee et al., 2015). Asthma-associated SNPs in this locus are related to levels of mRNA expression of ORMDL3 in lymphoblastic cell lines using eQTL mapping, which associates SNPs with gene expression (El-Husseini et al., 2020). Non-synonymous SNP of The IL7R (rs6897932) and IL2RB (rs2284033) (Arenas-Ramirez et al., 2015) regulate asthma by regulating type II inflammation via activating three pathways: JAK-STAT, PI3K-Akt-mTOR (Patel and Chang, 2012), and MEK-ERK (El-Husseini et al., 2020). Approximately 88% of the disease-associated variants acquired from genome-wide association studies (GWASs) reside in non-coding regions (El-Husseini et al., 2020). Examples of pathways or networks that are implicated by GWASs in asthma are the IL33-IL1-RL1 receptor pathway, leading to eosinophilia, and the T-helper-2 (Th2) cytokine IL-5 and IL-4RA receptor, leading to eosinophilia and type 2 inflammation or viral response (CDHR3, ORMDL3⁾ (Zhang et al., 2019a; Basnet et al., 2019). For example, genetic variation at chromosome 17q12-21 is associated with childhood asthma but not adult asthma (Ferreira et al., 2019; Pividori et al., 2019). Subsequent investigations also linked SNPs at this locus to GSDMA, GSDMB, CRKRS, ZBPB2, and IKZF2 expression in whole blood cells and lung tissue.

NcRNAs in the Regulation of Childhood Asthma

NcRNAs are a class of RNA transcripts that do not encode proteins, but they have been implicated in regulating gene expression at the epigenetic, transcriptional and post-transcriptional levels and affect the biological functions such as immune response, tissue repair and remodeling (Cech and Steitz, 2014; Cai et al., 2015; Xie and Liu, 2015; Zhang et al., 2019b). Mounting studies have shown that ncRNAs are involved in the occurrence and progression of childhood asthma. In this review, we mainly focus on the regulatory role of ncRNAs in the pathogenesis of childhood asthma and discuss the feasibility of ncRNAs as new biomarkers for the treatment of childhood asthma (Fasanaro et al., 2015) (Table 1).

Long Non-Coding RNAs in the Regulation of Childhood Asthma

LncRNAs, with a length of over 200 nt, play critical roles in regulating gene expression at multiple levels, including transcriptional, post-transcriptional levels, microRNA chelation and translation efficiency regulation and more (Hao and Zan, 2021; Wang et al., 2021). Although many studies have proved that lncRNAs and childhood asthma are inextricably linked (Wang et al., 2021), the roles of lncRNAs in childhood asthma remain unclear.

Recently, it has been reported that lncRNAs participate in regulating airway inflammation and remodeling (Ezegbunam and Foronjy, 2018; Liu et al., 2019a; Li et al., 2020a), and are helpful to further determine the biomarkers and therapeutic target of childhood asthma. Increasing numbers of studies suggest that lncRNAs affect the regulation of immune response, airway inflammation and cytokine expression (Dai et al., 2021). Moreover, lncRNAs also participate in the regulation of T helper (Th)1/Th2 imbalance, T regulatory (Treg)/Th17 imbalance, eosinophils dysfunction, macrophage polarization, airway smooth muscle cells (ASMCs) proliferation and so on (Zhu et al., 2020), to mediate childhood asthma.

Studies have found that LNC-000127 was not only closely related to Th2 inflammation but also positively regulated eosinophilic asthma. Malat1 has capability to modulate Th1/Th2 balance in asthma via MALAT1/miR-155/CTLA-4 axis. Therefore, MALAT1 and LNC-000127 could be used as a biomarker for eosinophilic asthma (Zhu et al., 2019). Additionally, Treg/Th17 imbalance was also associated with childhood asthma through neutrophil recruitment and exacerbation of airway inflammation, which was mediated by upregulating Th17-type cytokines (IL-17A, IL-17F) and downregulating Treg-type cytokines (IL-10, transforming growth factor (TGF-β) and so on (Westfall et al., 2021). LncRNA MEG3 regulated RORgammat expression by competitively sponge miR-17 and ultimately affected the balance of Treg/Th17 (Qiu et al., 2019; Hao and Zan, 2021; Wang et al., 2021). In addition, lncRNA RP11-401.2 upregulated in eosinophils dysfunction regulated eosinophilic asthma (Tian et al., 2018). Lnc-BAZ2B promoted M2 macrophage activation and was significantly upregulated in childhood asthma, whereas LncRNA PTPRE-AS1 was downregulated in macrophage polarization which mediated type II inflammation (Zeng et al., 2019). Regretfully, the detailed regulated mechanism of lncRNAs in childhood asthma is unclear. Besides, microarray analysis of CD4⁺ T cells of asthma patients showed that lncRNA ENST00000583179, lncRNA ENST00000579468 and lncRNA ENST00000444682 were positively correlated with the expression of IL-5 and IL-13, while lncRNA ENST00000583179 was positively correlated with the expression of IL-4 and IL-6. Interestingly, lncRNAs also regulated the expression of cytokines (IL-5 and IL-13), transcription factors (STAT5 and STAT6) and chemokines (CCL17 and CCL22), which mediated Th1 and Th2 inflammatory response in asthma. Nevertheless, its role in the pathogenesis of asthma remains to be further studied (Wang et al., 2017). Recently, lncRNAs SNHG8 and LINC01559 have been found to be directly involved in the occurrence and progression of childhood asthma through PI3K/AKT signaling pathway (Hao and Zan, 2021), and may serve as candidates for therapeutic strategies for childhood asthma (Table 2). Further elucidating the role of various lncRNAs in childhood asthma will help to understand the pathogenesis of asthma and develop potential treatment targets.

In sum, lncRNAs associated with cytokines, Th2-related transcription factors (STAT5 and STAT6) and Th2 related chemokines (CCL17 and CCL22) to affect the balance of Th1/Th2 (Wang et al., 2017). In addition, lncRNAs may act as regulator of Th1 and Th2 inflammation in the pathogenesis of asthma through lncRNA-miRNA-mRNA axis. For example, lncRNA fantom3-9230106C11 binded to miRNAs and transcription factors to mediate Th2 cell differentiation and regulated Th2 inflammation (Wang et al., 2019). However, only a small number of lncRNAs were applied to the clinical diagnosis and treatment of childhood asthma. Further research associated with lncRNAs is needed in the field of asthma therapy.

MicroRNAs Act on Target Pathways and Regulatory Mechanisms of Childhood Asthma

MiRNAs are a class of small ncRNAs (approximately 21–25 nucleotides) that regulate gene expression and cellular function by primarily bind to the 3′ untranslated region (3′ UTR) of mRNAs (Simpson et al., 2014; Kho et al., 2018). MiRNAs play vital roles in regulating Th2 activation, differentiation and proliferation by directly or indirectly acting on target genes (Rebane and Akdis, 2013; Qiu et al., 2018). On one hand, miRNAs regulate airway inflammation of childhood asthma by increasing Th2 cytokine secretion to decrease Th1 cytokine secretion and promote the differentiation of CD4⁺ T cells into Th2 (Midyat et al., 2016; Aripova et al., 2020). On the other hand, miRNAs also play roles in hyperplasia and hypertrophy of airway smooth muscle cells (Specjalski and Niedoszytko, 2020).

MiRNAs are involved in the pathogenesis of asthma by regulating inflammatory reaction. Specifically speaking, a core set of miRNAs were involved in childhood asthma including the downregulated let-7 family and upregulated miR-155, miR-21, miR-142-5p, miR-142-3p, miR-223, and miR-146a/b, etc. (Specjalski and Niedoszytko, 2020; van den Berge and Tasena, 2019). Let-7 microRNAs belongs to a family of highly conserved microRNA and comprises the most abundant miRNAs in lungs (Karam and Abd Elrahman, 2019; Cañas et al., 2020). Kumar et al. (2014) showed that let-7 family members were decreased in ovalbumin-sensitized animal models (Huang et al., 2020; Weidner et al., 2021), playing a proinflammatory role in asthma. Furthermore, let-7 family inhibited the secretion of IL-13 by directly targeting IL-13 transcript (Huang et al., 2020; Xu et al., 2020). Among numerous miRNAs reviewed in this field, miR-146, miR-155, and miR-223 have been identified as inflammatory response miRNAs that are up-regulated by NF-κB (Boldin and Baltimore, 2012; Kumar et al., 2014). MiRNA-21 is involved in the pathogenesis of asthma by limiting the activation of IL-12/IFN-γ and the differentiation of Th1 and Th2. It has been described that lack of miR-21 in mice may cause the increasion of levels of IFN-γ secreted by Th1 cells and the decreasion of pulmonary eosinophils, hence inhibiting the inflammation (Das et al., 2014).

MiRNAs are also involved in airway remodeling in asthmatic mice model. Ras homolog family member A (RhoA) of the Rho family GTPases regulated airway remodeling through regulating mesenchymal stem cell (MSC) differentiation. MiR-133a negatively regulated RhoA expression and bronchial smooth muscle cells (BSMCs) contraction (Chiba, 2020) to influence airway remodeling. Moreover, miR-26a induced human airway smooth muscle cells (HASMCs) hypertrophy (Mohamed et al., 2010). MiR-10a reduced mitogen-induced HASMCs proliferation (Hu et al., 2014) to regulate airway remodeling.

MiRNAs are not only the regulators in asthma pathogenesis, but also the targets of asthma therapeutics. Further studies illustrated miRNAs inhibited asthma through downregulation or antagonism of disease-related miRNA (Wang, 2010). Growing evidence showed that up-regulated miRNAs could be inhibited by miRNAs inhibitors or synthetic miRNAs oligonucleotides against miRNAs activity, and the administration of miRNAs inducers that increased tissue-specific miRNAs expression might be another treatment for asthma (Lukiw, 2013; He et al., 2014). For example, miR-155 knockout and miR-106a knockdown alleviated asthma though diminishing airway inflammation, mucus hypersecretion and airway Th2 cytokine levels (Mattes et al., 2009; Huang et al., 2014; Malmhäll et al., 2014). MiRNA-221 blockade suppressed airway inflammation. Moreover, Let-7 miRNA inhibition reduced airway hyperresponsiveness and subepithelial fibrosis by decreasing IL-13 levels to suppress airway inflammation and attenuate mucus metaplasia (Chiba et al., 2009; Kumar et al., 2011) (Table 3).

CircRNAs in the Regulation of Childhood Asthma

CircRNAs are a special class of ncRNAs that function as miRNA sponges to indirectly regulate downstream mRNA expression and epigenetically influence various biological processes, especially in cancers (Zhao et al., 2019; Huang et al., 2021b). However, the contribution of circRNAs to childhood asthma progression remains unknown. In recent years, circRNAs have attracted extensive attention in the pathogenesis of childhood asthma.

Huang et al. (2019) showed that circ-0005519 could regulate the secretion of IL-13/IL-6 by competitively sponging let-7a-5p in CD4⁺ T cells from asthma. Previous studies also found that circ-0002594 was a proinflammatory factor in Th2-mediated asthma (Huang et al., 2021b). Circ-0000723 could sponge miR-214 to impact the balance of Th1/Th2 by runt-related transcription factor (RUNX) signal transduction. Moreover, circRNAs also play vital roles in airway smooth muscle cells (ASMCs). Mounting evidence showed that circERBB2 and circHIPK3 could sponge miR-98-5p and miR-326, respectively, and promoted the proliferation of ASMCs by targeting IGF1R and STIM1 (Lin et al., 2020; Huang et al., 2021c). Circ-0001359 could attenuate airway remodeling by targeting FoxO1-dependent M2-like macrophage activation, with sponging miR-183-5p (Shang et al., 2020; Mathis et al., 2021) (Table 4). At present, although there are many studies on the competitively sponging of circRNAs to miRNAs, the specific effect of these circRNAs on asthma is not completely clear. So, the pathogenesis of circRNAs in childhood asthma should be further studied in order to seek for potential diagnostic and therapeutic targets of childhood asthma, which can be used as a new direction of targeted drug therapy.

NcRNAs Function as Targets for Asthma Diagnosis and Treatment

Although high-dose inhaled corticosteroids and long-acting β2 agonists have been improved for the treatment of asthma, none of these treatments have been shown to alter the natural history of the asthma, and some patients are still failing in these treatments (Sweeney et al., 2012). NcRNAs play an essential role in the treatment and prognosis of asthma. Hence, asthma has been turned to lncRNAs, miRNAs and circRNAs in search of new breakthroughs (Zampetaki et al., 2012; Milagro et al., 2013). Evidences have implicited that lncRNAs, miRNAs and circRNAs can be used as biomarkers of sensitivity and early diagnosis of asthma (Zampetaki et al., 2012). For instance, the expression of lncRNA CASC2 in serum was at a lower level in asthma children than healthy individuals, which suggested that lncRNA CASC2 might be involved in childhood asthma (Yang et al., 2022). Moreover, lnc-BAZ2B also played a crucial role in exacerbating the progression of childhood asthma (Xia et al., 2021). It can be inferred that lncRNA CASC2 and lnc-BAZ2B may serve as potential diagnostic biomarkers, and are expected to become new targets for childhood asthma treatment in the near future. Besides, many surveys have identified that miRNAs such as let-7a, miR-146b-5p, miR-21, miR-532-5p, miR-155 and so on, are promising to be used as diagnostic biomarkers and therapeutic targets in childhood asthma (Kho et al., 2018; Li et al., 2020b; Xu et al., 2020). CircRNAs also play crucial roles to regulate childhood asthma through circRNA-miRNA-mRNA regulatory network and can be served as potential biomarkers and therapeutic targets in childhood asthma (Chen et al., 2021; Wang et al., 2022). Although siRNAs are one of the regulatory ncRNAs, seldom studies have demonstrated the roles of siRNAs in the pathogenesis of childhood asthma. Recently, only several studies have implicated the therapeutic effects of synthetic siRNA in allergen-induced asthma models (Miyamoto et al., 2011; Chen et al., 2017). Consequently, research of drugs related to ncRNAs, especially lncRNAs, miRNAs and circRNAs, may become a new direction in the field of targeted asthma therapy.

Conclusion and Perspective

In this review, we mainly discuss childhood asthma. Children are special categories of patients and the symptoms of many other diseases are similar with asthma, which makes the diagnosis of asthma difficult. This review provides a novel strategy to diagnose and treat childhood asthma by targeting ncRNAs. Despite the treatment of asthma by inhaling corticosteroids, long acting β agonists, and leukotriene modifiers could reduce symptoms, the burden of asthma remains high. As far as childhood asthma, there is no evidence that early treatment decreases the risk of subsequent asthma or alters its natural history (Depner et al., 2014; Ducharme et al., 2014). It is widely quoted that 5–10% of the asthmatic population have severe asthma, suffering a significant health and socioeconomic burden (Papi et al., 2018; Agache et al., 2021). Facing these challenges, biomarker-directed therapy is more and more attractive and biomarkers for asthma have potential utility for distinguishing the inflammatory endotype, predicting responsiveness to specific treatments, monitoring success of a selected treatment option, and assessing the risk of disease progression (Agache and Rogozea, 2017; Cosmi et al., 2017). Accordingly, the discovery of lncRNAs, miRNAs and circRNAs offers a new opportunity for understanding the pathogenesis of childhood asthma (Rundell et al., 2015) and it is necessary to develop ncRNAs as new therapeutic targets for asthma.

Clinically, we still lack effective treatment measures for refractory asthma. NcRNAs have been considered to be one of the most promising and novel therapeutic targets for childhood asthma. Correctly, lncRNAs contributing to the regulation of airway remodeling and glucocorticoid sensitivity during transcription make it a potential biomarker for the preclinical identification, diagnosis, prognosis, phenotypes of asthma as well as therapeutic targets. However, there is no research to discuss the relationship between lncRNAs and Th2 cell and T follicular helper cells, which might be the focus of future research. In the same way, miRNAs also have multiple potential targets that may coordinate or antagonize each other’s functions. Restoring normal physiological levels of miRNAs in asthma, such as miRNA mimics, inhibitors, might have the potential to improve clinical outcomes (Ameis et al., 2017). Actually, ncRNAs still exist limitations, for example, how to accurately locate at a specific target or a certain organ, and whether through specific chemical modification of nucleic acid drugs or not, possible off-target effects of nucleic acid drug, etc. which is still worth exploring. Besides, there are still some unexpected side effects on ncRNAs, such as the disruption of the immune response and incompleteness during the treatment because of individual differences and so on. Luckily, if given appropriate immunotherapy and individualized treatment, these side effects may be reduced.

Nevertheless, due to complicated crosstalks between ncRNAs and inflammatory pathways in asthma, the expression of single lncRNAs, miRNAs and circRNAs may not be a truly reliable biomarker. Thus, several attempts have been made in finding asthma associated with pathways to provide a new avenue to treat asthma. For example, the metastatic-associated lung adenocarcinoma transcript 1 (MALAT1)/miR-155/CTLA-4 axis has the ability to regulate Th1/Th2 balance in asthma. MALAT1 is upregulated in the blood of asthmatic patients, while the miR-155 is downregulated, and the Th1/Th2 ratio is decreased, which suggests that Th1 inflammation is weakened and Th2 inflammation is amplified, so it can be used as a marker of inflammatory disorders in asthma (Liang and Tang, 2020). Thus, future studies should be more focused on human settings. Application of lncRNAs, miRNAs and circRNAs as non-invasive biomarkers should be investigated with an emphasis of possible determination of disease endotype and predicting treatment effects. Recently, the roles of all ncRNAs in the pathogenesis of childhood asthma have not been clarified, which should be further studied in order to seek for potential diagnostic and therapeutic targets of childhood asthma.

References

• 1

  AbdullahiM.RanjbaranR.AlyasinS.KeshavarzZ.RamezaniA.Behzad-BehbahaniA.et al (2016). Expression of Basophil Activation Markers in Pediatric Asthma. Iran J. Immunol.13 (1), 27–36.

  • Google Scholar

• 2

  AgacheI.Eguiluz-GraciaI.CojanuC.LaculiceanuA.Del GiaccoS.Zemelka-WiacekM.et al (2021). Advances and Highlights in Asthma in 2021. Allergy76 (11), 3390–3407. 10.1111/all.15054

  • CrossRef
  • Google Scholar

• 3

  AgacheI.RogozeaL. (2017). Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?Allergy Asthma Immunol. Res.9 (6), 466–476. 10.4168/aair.2017.9.6.466

  • CrossRef
  • Google Scholar

• 4

  AlamR.GorskaM. M. (2011). Mitogen-activated Protein Kinase Signalling and ERK1/2 Bistability in Asthma. Clin. Exp. Allergy41 (2), 149–159. 10.1111/j.1365-2222.2010.03658.x

  • CrossRef
  • Google Scholar

• 5

  AlizadehZ.MortazE.AdcockI.MoinM. (2017). Role of Epigenetics in the Pathogenesis of Asthma. Iran J. Allergy Asthma Immunol.16 (2), 82–91.

  • Google Scholar

• 6

  AltmanM. C.GillM. A.WhalenE.BabineauD. C.ShaoB.LiuA. H.et al (2019). Transcriptome Networks Identify Mechanisms of Viral and Nonviral Asthma Exacerbations in Children. Nat. Immunol.20 (5), 637–651. 10.1038/s41590-019-0347-8

  • CrossRef
  • Google Scholar

• 7

  AmeisD.KhoshgooN.IwasiowB. M.SnarrP.KeijzerR. (2017). MicroRNAs in Lung Development and Disease. Paediatr. Respir. Rev.22, 38–43. 10.1016/j.prrv.2016.12.002

  • CrossRef
  • Google Scholar

• 8

  Arenas-RamirezN.WoytschakJ.BoymanO. (2015). Interleukin-2: Biology, Design and Application. Trends Immunol.36 (12), 763–777. 10.1016/j.it.2015.10.003

  • CrossRef
  • Google Scholar

• 9

  AripovaA.AkparovaA.BersimbaevR. (2020). Moderate Bronchial Asthma. Microrna. 10.2174/2211536609666201221122715

  • CrossRef
  • Google Scholar

• 10

  AssafS. M.HananiaN. A. (2019). Biological Treatments for Severe Asthma. Curr. Opin. Allergy Clin. Immunol.19 (4), 379–386. 10.1097/ACI.0000000000000549

  • CrossRef
  • Google Scholar

• 11

  AustinP. J.TsitsiouE.BoardmanC.JonesS. W.LindsayM. A.AdcockI. M.et al (2017). Transcriptional Profiling Identifies the Long Noncoding RNA Plasmacytoma Variant Translocation (PVT1) as a Novel Regulator of the Asthmatic Phenotype in Human Airway Smooth Muscle. J. Allergy Clin. Immunol.139 (3), 780–789. 10.1016/j.jaci.2016.06.014

  • CrossRef
  • Google Scholar

• 12

  BarnigC.CernadasM.DutileS.LiuX.PerrellaM. A.KazaniS.et al (2013). Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma. Sci. Transl Med.5 (174), 174ra26. 10.1126/scitranslmed.3004812

  • CrossRef
  • Google Scholar

• 13

  BarnigC.LevyB. D. (2015). Innate Immunity Is a Key Factor for the Resolution of Inflammation in Asthma. Eur. Respir. Rev.24 (135), 141–153. 10.1183/09059180.00012514

  • CrossRef
  • Google Scholar

• 14

  BasnetS.BochkovY. A.Brockman-SchneiderR. A.KuipersI.AesifS. W.JacksonD. J.et al (2019). CDHR3 Asthma-Risk Genotype Affects Susceptibility of Airway Epithelium to Rhinovirus C Infections. Am. J. Respir. Cel Mol Biol61 (4), 450–458. 10.1165/rcmb.2018-0220OC

  • CrossRef
  • Google Scholar

• 15

  BéginP.NadeauK. C. (2014). Epigenetic Regulation of Asthma and Allergic Disease. Allergy Asthma Clin. Immunol.10 (1), 27. 10.1186/1710-1492-10-27

  • CrossRef
  • Google Scholar

• 16

  BoldinM. P.BaltimoreD. (2012). MicroRNAs, New Effectors and Regulators of NF-Κb. Immunol. Rev.246 (1), 205–220. 10.1111/j.1600-065X.2011.01089.x

  • CrossRef
  • Google Scholar

• 17

  BondS.LéguilletteR.RichardE. A.CouetilL.LavoieJ. P.MartinJ. G.et al (2018). Equine Asthma: Integrative Biologic Relevance of a Recently Proposed Nomenclature. J. Vet. Intern. Med.32 (6), 2088–2098. 10.1111/jvim.15302

  • CrossRef
  • Google Scholar

• 18

  CaiZ.ZengW.TaoK.EZ.WangB.YangQ. (2015). Chaperone-mediated Autophagy: Roles in Neuroprotection. Neurosci. Bull.31 (4), 452–458. 10.1007/s12264-015-1540-x

  • CrossRef
  • Google Scholar

• 19

  CañasJ. A.Rodrigo-MuñozJ. M.SastreB.Gil-MartinezM.RedondoN.Del PozoV. (2020). MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease. Front. Immunol.11, 608666. 10.3389/fimmu.2020.608666

  • CrossRef
  • Google Scholar

• 20

  CastanL.BøghK. L.MaryniakN. Z.EpsteinM. M.KazemiS.O'MahonyL.et al (2020). Overview of In Vivo and Ex Vivo Endpoints in Murine Food Allergy Models: Suitable for Evaluation of the Sensitizing Capacity of Novel Proteins?Allergy75 (2), 289–301. 10.1111/all.13943

  • CrossRef
  • Google Scholar

• 21

  CechT. R.SteitzJ. A. (2014). The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones. Cell157 (1), 77–94. 10.1016/j.cell.2014.03.008

  • CrossRef
  • Google Scholar

• 22

  ChenD.WuW.YiL.FengY.ChangC.ChenS.et al (2021). A Potential circRNA-miRNA-mRNA Regulatory Network in Asthmatic Airway Epithelial Cells Identified by Integrated Analysis of Microarray Datasets. Front. Mol. Biosci.8, 703307. 10.3389/fmolb.2021.703307

  • CrossRef
  • Google Scholar

• 23

  ChenH.XuX.ChengS.XuY.XuefeiQ.CaoY.et al (2017). Small Interfering RNA Directed against microRNA-155 Delivered by a Lentiviral Vector Attenuates Asthmatic Features in a Mouse Model of Allergic Asthma. Exp. Ther. Med.14 (5), 4391–4396. 10.3892/etm.2017.5093

  • CrossRef
  • Google Scholar

• 24

  ChibaY. (2020). Non-coding RNAs and Bronchial Smooth Muscle Hyperresponsiveness in Allergic Bronchial Asthma. Nihon Yakurigaku Zasshi155 (6), 364–368. 10.1254/fpj.20053

  • CrossRef
  • Google Scholar

• 25

  ChibaY.TanabeM.GotoK.SakaiH.MisawaM. (2009). Down-regulation of miR-133a Contributes to Up-Regulation of Rhoa in Bronchial Smooth Muscle Cells. Am. J. Respir. Crit. Care Med.180 (8), 713–719. 10.1164/rccm.200903-0325OC

  • CrossRef
  • Google Scholar

• 26

  ChogtuB.BhattacharjeeD.MagazineR. (2016). Epigenetics: The New Frontier in the Landscape of Asthma. Scientifica (Cairo)2016, 4638949. 10.1155/2016/4638949

  • CrossRef
  • Google Scholar

• 27

  CosmiL.LiottaF.MaggiL.AnnunziatoF. (2017). Role of Type 2 Innate Lymphoid Cells in Allergic Diseases. Curr. Allergy Asthma Rep.17 (10), 66. 10.1007/s11882-017-0735-9

  • CrossRef
  • Google Scholar

• 28

  DaiB.SunF.CaiX.LiC.LiuF.ShangY. (2021). Long Noncoding RNA PTTG3P/miR-192-3p/CCNB1 axis Is a Potential Biomarker of Childhood Asthma. Int. Immunopharmacol101 (Pt B), 108229. 10.1016/j.intimp.2021.108229

  • CrossRef
  • Google Scholar

• 29

  DasA.GaneshK.KhannaS.SenC. K.RoyS. (2014). Engulfment of Apoptotic Cells by Macrophages: a Role of microRNA-21 in the Resolution of Wound Inflammation. J. Immunol.192 (3), 1120–1129. 10.4049/jimmunol.1300613

  • CrossRef
  • Google Scholar

• 30

  DefnetA. E.HuangW.PolischakS.YadavS. K.KaneM. A.ShapiroP.et al (2019). Effects of ATP-Competitive and Function-Selective ERK Inhibitors on Airway Smooth Muscle Cell Proliferation. FASEB J.33 (10), 10833–10843. 10.1096/fj.201900680R

  • CrossRef
  • Google Scholar

• 31

  DepnerM.FuchsO.GenuneitJ.KarvonenA. M.HyvärinenA.KaulekV.et al (2014). Clinical and Epidemiologic Phenotypes of Childhood Asthma. Am. J. Respir. Crit. Care Med.189 (2), 129–138. 10.1164/rccm.201307-1198OC

  • CrossRef
  • Google Scholar

• 32

  DeschildreA.PichavantM.EngelmannI.LangloisC.DrumezE.PouesselG.et al (2017). Virus-triggered Exacerbation in Allergic Asthmatic Children: Neutrophilic Airway Inflammation and Alteration of Virus Sensors Characterize a Subgroup of Patients. Respir. Res.18 (1), 191. 10.1186/s12931-017-0672-0

  • CrossRef
  • Google Scholar

• 33

  DongX.XuM.RenZ.GuJ.LuM.LuQ.et al (2016). Regulation of CBL and ESR1 Expression by microRNA-22-3p, 513a-5p and 625-5p M-ay I-mpact the P-athogenesis of D-ust M-ite-I-nduced P-ediatric A-sthma. Int. J. Mol. Med.38 (2), 446–456. 10.3892/ijmm.2016.2634

  • CrossRef
  • Google Scholar

• 34

  DriscollA. J.ArshadS. H.BontL.BrunwasserS. M.CherianT.EnglundJ. A.et al (2020). Does Respiratory Syncytial Virus Lower Respiratory Illness in Early Life Cause Recurrent Wheeze of Early Childhood and Asthma? Critical Review of the Evidence and Guidance for Future Studies from a World Health Organization-Sponsored Meeting. Vaccine38 (11), 2435–2448. 10.1016/j.vaccine.2020.01.020

  • CrossRef
  • Google Scholar

• 35

  DucharmeF. M.TseS. M.ChauhanB. (2014). Diagnosis, Management, and Prognosis of Preschool Wheeze. Lancet383 (9928), 1593–1604. 10.1016/S0140-6736(14)60615-2

  • CrossRef
  • Google Scholar

• 36

  El-HusseiniZ. W.GosensR.DekkerF.KoppelmanG. H. (2020). The Genetics of Asthma and the Promise of Genomics-Guided Drug Target Discovery. Lancet Respir. Med.8 (10), 1045–1056. 10.1016/S2213-2600(20)30363-5

  • CrossRef
  • Google Scholar

• 37

  ElnadyH. G.SherifL. S.KholoussiN. M.Ali AzzamM.FodaA. R.HelwaI.et al (2020). Aberrant Expression of Immune-Related MicroRNAs in Pediatric Patients with Asthma. Int. J. Mol. Cel Med9 (4), 246–255. 10.22088/IJMCM.BUMS.9.4.246

  • CrossRef
  • Google Scholar

• 38

  EnomotoY.OriharaK.TakamasuT.MatsudaA.GonY.SaitoH.et al (2009). Tissue Remodeling Induced by Hypersecreted Epidermal Growth Factor and Amphiregulin in the Airway after an Acute Asthma Attack. J. Allergy Clin. Immunol.124 (5), 913–917. 10.1016/j.jaci.2009.08.044

  • CrossRef
  • Google Scholar

• 39

  EzegbunamW.ForonjyR. (2018). Posttranscriptional Control of Airway Inflammation. Wiley Interdiscip. Rev. RNA9 (1). 10.1002/wrna.1455

  • CrossRef
  • Google Scholar

• 40

  FanM.XuJ.XiaoQ.ChenF.HanX. (2019). Long Non-coding RNA TCF7 Contributes to the Growth and Migration of Airway Smooth Muscle Cells in Asthma through Targeting TIMMDC1/Akt axis. Biochem. Biophys. Res. Commun.508 (3), 749–755. 10.1016/j.bbrc.2018.11.187

  • CrossRef
  • Google Scholar

• 41

  FasanaroP.D'AlessandraY.MagentaA.PompilioG.CapogrossiM. C. (2015). microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia. Curr. Vasc. Pharmacol.13 (3), 305–315. 10.2174/15701611113119990011

  • CrossRef
  • Google Scholar

• 42

  FerreiraM. A. R.MathurR.VonkJ. M.SzwajdaA.BrumptonB.GranellR.et al (2019). Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. Am. J. Hum. Genet.104 (4), 665–684. 10.1016/j.ajhg.2019.02.022

  • CrossRef
  • Google Scholar

• 43

  FosterP. S.MaltbyS.RosenbergH. F.TayH. L.HoganS. P.CollisonA. M.et al (2017). Modeling TH 2 Responses and Airway Inflammation to Understand Fundamental Mechanisms Regulating the Pathogenesis of Asthma. Immunol. Rev.278 (1), 20–40. 10.1111/imr.12549

  • CrossRef
  • Google Scholar

• 44

  FratiF.SalvatoriC.IncorvaiaC.BellucciA.Di CaraG.MarcucciF.et al (2018). The Role of the Microbiome in Asthma: The Gut⁻Lung Axis. Int. J. Mol. Sci.20 (1), 123. 10.3390/ijms20010123

  • CrossRef
  • Google Scholar

• 45

  GaoH.YingS.DaiY. (2017). Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and its Potential for Therapy as a Target. J. Immunol. Res.2017, 3743048. 10.1155/2017/3743048

  • CrossRef
  • Google Scholar

• 46

  Haktanir AbulM.PhipatanakulW. (2019). Severe Asthma in Children: Evaluation and Management. Allergol. Int.68 (2), 150–157. 10.1016/j.alit.2018.11.007

  • CrossRef
  • Google Scholar

• 47

  HammadH.LambrechtB. N. (2021). The Basic Immunology of Asthma. Cell184 (6), 1469–1485. 10.1016/j.cell.2021.02.016

  • CrossRef
  • Google Scholar

• 48

  HaoM.ZanJ. (2021). The Identification of Childhood Asthma Progression-Related lncRNAs and mRNAs Suitable as Biomarkers Using Weighted Gene Coexpression Network Analysis. Genet. Res. (Camb)2021, 5511507. 10.1155/2021/5511507

  • CrossRef
  • Google Scholar

• 49

  HeX.JingZ.ChengG. (2014). MicroRNAs: New Regulators of Toll-like Receptor Signalling Pathways. Biomed. Res. Int.2014, 945169. 10.1155/2014/945169

  • CrossRef
  • Google Scholar

• 50

  HolgateS. T.WenzelS.PostmaD. S.WeissS. T.RenzH.SlyP. D. (2015). Asthma. Nat. Rev. Dis. Primers1 (1), 15025. 10.1038/nrdp.2015.25

  • CrossRef
  • Google Scholar

• 51

  HuR.PanW.FedulovA. V.JesterW.JonesM. R.WeissS. T.et al (2014). MicroRNA-10a Controls Airway Smooth Muscle Cell Proliferation via Direct Targeting of the PI3 Kinase Pathway. FASEB J.28 (5), 2347–2357. 10.1096/fj.13-247247

  • CrossRef
  • Google Scholar

• 52

  HuangF.JiaH.ZouY.YaoY.DengZ. (2020). Exosomes: an Important Messenger in the Asthma Inflammatory Microenvironment. J. Int. Med. Res.48 (2), 300060520903220. 10.1177/0300060520903220

  • CrossRef
  • Google Scholar

• 53

  HuangG.SuJ.ZhaoW.DengZ.WangP.DongH.et al (2021). JNK Modulates RAGE/β-catenin Signaling and Is Essential for Allergic Airway Inflammation in Asthma. Toxicol. Lett.336, 57–67. 10.1016/j.toxlet.2020.10.002

  • CrossRef
  • Google Scholar

• 54

  HuangJ. Q.WangF.WangL. T.LiY. M.LuJ. L.ChenJ. Y. (2021). Circular RNA ERBB2 Contributes to Proliferation and Migration of Airway Smooth Muscle Cells via miR-98-5p/IGF1R Signaling in Asthma. J. Asthma Allergy14, 1197–1207. 10.2147/JAA.S326058

  • CrossRef
  • Google Scholar

• 55

  HuangY.LiuY.LiL.SuB.YangL.FanW.et al (2014). Involvement of Inflammation-Related miR-155 and miR-146a in Diabetic Nephropathy: Implications for Glomerular Endothelial Injury. BMC Nephrol.15, 142. 10.1186/1471-2369-15-142

  • CrossRef
  • Google Scholar

• 56

  HuangZ.CaoY.ZhouM.QiX.FuB.MouY.et al (2019). Hsa_circ_0005519 Increases IL-13/IL-6 by Regulating Hsa-Let-7a-5p in CD4+ T Cells to Affect Asthma. Clin. Exp. Allergy49 (8), 1116–1127. 10.1111/cea.13445

  • CrossRef
  • Google Scholar

• 57

  HuangZ.FuB.QiX.XuY.MouY.ZhouM.et al (2021). Diagnostic and Therapeutic Value of Hsa_circ_0002594 for T Helper 2-Mediated Allergic Asthma. Int. Arch. Allergy Immunol.182 (5), 388–398. 10.1159/000511612

  • CrossRef
  • Google Scholar

• 58

  HuoR.TianX.ChangQ.LiuD.WangC.BaiJ.et al (2021). Targeted Inhibition of β-catenin Alleviates Airway Inflammation and Remodeling in Asthma via Modulating the Profibrotic and Anti-inflammatory Actions of Transforming Growth Factor-Β1. Ther. Adv. Respir. Dis.15, 1753466620981858. 10.1177/1753466620981858

  • CrossRef
  • Google Scholar

• 59

  InoueH.AkimotoK.HommaT.TanakaA.SagaraH. (2020). Airway Epithelial Dysfunction in Asthma: Relevant to Epidermal Growth Factor Receptors and Airway Epithelial Cells. J. Clin. Med.9 (11), 3698. 10.3390/jcm9113698

  • CrossRef
  • Google Scholar

• 60

  JatK. R.KabraS. K. (2017). Awareness about Childhood Asthma. Indian J. Med. Res.145 (5), 581–583. 10.4103/ijmr.IJMR_420_17

  • CrossRef
  • Google Scholar

• 61

  JiaX. X.ZhuT. T.HuangY.ZengX. X.ZhangH.ZhangW. X. (2019). Wnt/β-catenin Signaling Pathway Regulates Asthma Airway Remodeling by Influencing the Expression of C-Myc and Cyclin D1 via the P38 MAPK-dependent Pathway. Exp. Ther. Med.18 (5), 3431–3438. 10.3892/etm.2019.7991

  • CrossRef
  • Google Scholar

• 62

  JiangY.GuoX.QinJ. (2021). Silencing of circHIPK3 Hampers Platelet-Derived Growth Factor-Induced Proliferation and Migration in Airway Smooth Muscle Cells through the miR-375/MMP-16 axis. Cytotechnology73 (4), 629–642. 10.1007/s10616-021-00483-2

  • CrossRef
  • Google Scholar

• 63

  KabeschM.TostJ. (2020). Recent Findings in the Genetics and Epigenetics of Asthma and Allergy. Semin. Immunopathol42 (1), 43–60. 10.1007/s00281-019-00777-w

  • CrossRef
  • Google Scholar

• 64

  KaramR. A.Abd ElrahmanD. M. (2019). Differential Expression of miR-155 and Let-7a in the Plasma of Childhood Asthma: Potential Biomarkers for Diagnosis and Severity. Clin. Biochem.68, 30–36. 10.1016/j.clinbiochem.2019.04.007

  • CrossRef
  • Google Scholar

• 65

  KärnerJ.WawrzyniakM.TankovS.RunnelT.AintsA.KisandK.et al (2017). Increased microRNA-323-3p in IL-22/IL-17-producing T Cells and Asthma: a Role in the Regulation of the TGF-β Pathway and IL-22 Production. Allergy72 (1), 55–65. 10.1111/all.12907

  • CrossRef
  • Google Scholar

• 66

  KhoA. T.McGeachieM. J.MooreK. G.SylviaJ. M.WeissS. T.TantisiraK. G. (2018). Circulating microRNAs and Prediction of Asthma Exacerbation in Childhood Asthma. Respir. Res.19 (1), 128. 10.1186/s12931-018-0828-6

  • CrossRef
  • Google Scholar

• 67

  KimE. K.ChoiE. J. (2010). Pathological Roles of MAPK Signaling Pathways in Human Diseases. Biochim. Biophys. Acta1802 (4), 396–405. 10.1016/j.bbadis.2009.12.009

  • CrossRef
  • Google Scholar

• 68

  KimH. Y.DeKruyffR. H.UmetsuD. T. (2010). The many Paths to Asthma: Phenotype Shaped by Innate and Adaptive Immunity. Nat. Immunol.11 (7), 577–584. 10.1038/ni.1892

  • CrossRef
  • Google Scholar

• 69

  KimH. Y.LeeH. J.ChangY. J.PichavantM.ShoreS. A.FitzgeraldK. A.et al (2014). Interleukin-17-producing Innate Lymphoid Cells and the NLRP3 Inflammasome Facilitate Obesity-Associated Airway Hyperreactivity. Nat. Med.20 (1), 54–61. 10.1038/nm.3423

  • CrossRef
  • Google Scholar

• 70

  KirengaB.ChakayaJ.YimerG.NyaleG.HaileT.MuttambaW.et al (2020). Phenotypic Characteristics and Asthma Severity in an East African Cohort of Adults and Adolescents with Asthma: Findings from the African Severe Asthma Project. BMJ Open Respir. Res.7 (1), e000484. 10.1136/bmjresp-2019-000484

  • CrossRef
  • Google Scholar

• 71

  KoczullaA. R.VogelmeierC. F.GarnH.RenzH. (2017). New Concepts in Asthma: Clinical Phenotypes and Pathophysiological Mechanisms. Drug Discov. Today22 (2), 388–396. 10.1016/j.drudis.2016.11.008

  • CrossRef
  • Google Scholar

• 72

  KumarM.AhmadT.SharmaA.MabalirajanU.KulshreshthaA.AgrawalA.et al (2011). Let-7 microRNA-Mediated Regulation of IL-13 and Allergic Airway Inflammation. J. Allergy Clin. Immunol.128 (5), 1077–1110. 10.1016/j.jaci.2011.04.034

  • CrossRef
  • Google Scholar

• 73

  KumarV.PalermoR.TaloraC.CampeseA. F.ChecquoloS.BellaviaD.et al (2014). Notch and NF-kB Signaling Pathways Regulate miR-223/FBXW7 axis in T-Cell Acute Lymphoblastic Leukemia. Leukemia28 (12), 2324–2335. 10.1038/leu.2014.133

  • CrossRef
  • Google Scholar

• 74

  LambrechtB. N.HammadH. (2015). The Immunology of Asthma. Nat. Immunol.16 (1), 45–56. 10.1038/ni.3049

  • CrossRef
  • Google Scholar

• 75

  LampaloM.MajerM.FeraraN.MiloševićM.Barišić KutijaM.JukićI. (2019). Gender Differences in Relationship between Body Mass Index and Asthma. Psychiatr. Danub31 (Suppl. 5), 786–791.

  • Google Scholar

• 76

  LeeE.LeeS. H.KwonJ. W.KimY. H.YoonJ.ChoH. J.et al (2017). Persistent Asthma Phenotype Related with Late-Onset, High Atopy, and Low Socioeconomic Status in School-Aged Korean Children. BMC Pulm. Med.17 (1), 45. 10.1186/s12890-017-0387-5

  • CrossRef
  • Google Scholar

• 77

  LeeJ. U.KimJ. D.ParkC. S. (2015). Gene-Environment Interactions in Asthma: Genetic and Epigenetic Effects. Yonsei Med. J.56 (4), 877–886. 10.3349/ymj.2015.56.4.877

  • CrossRef
  • Google Scholar

• 78

  LeeJ. W.MinJ. H.KimM. G.KimS. M.KwonO. K.OhT. K.et al (2019). Pistacia Weinmannifolia Root Exerts a Protective Role in Ovalbumin-induced L-ung I-nflammation in a M-ouse A-llergic A-sthma M-odel. Int. J. Mol. Med.44 (6), 2171–2180. 10.3892/ijmm.2019.4367

  • CrossRef
  • Google Scholar

• 79

  LeeY. J.FujisawaT.KimC. K. (2019). Biomarkers for Recurrent Wheezing and Asthma in Preschool Children. Allergy Asthma Immunol. Res.11 (1), 16–28. 10.4168/aair.2019.11.1.16

  • CrossRef
  • Google Scholar

• 80

  LejeuneS.DeschildreA.Le RouzicO.EngelmannI.DesseinR.PichavantM.et al (2020). Childhood Asthma Heterogeneity at the Era of Precision Medicine: Modulating the Immune Response or the Microbiota for the Management of Asthma Attack. Biochem. Pharmacol.179, 114046. 10.1016/j.bcp.2020.114046

  • CrossRef
  • Google Scholar

• 81

  LiB.SunW. X.ZhangW. Y.ZhengY.QiaoL.HuY. M.et al (2021). The Transcriptome Characteristics of Severe Asthma from the Prospect of Co-expressed Gene Modules. Front. Genet.12, 765400. 10.3389/fgene.2021.765400

  • CrossRef
  • Google Scholar

• 82

  LiJ.PanganibanR.KhoA. T.McGeachieM. J.FarnamL.ChaseR. P.et al (2020). Circulating MicroRNAs and Treatment Response in Childhood Asthma. Am. J. Respir. Crit. Care Med.202 (1), 65–72. 10.1164/rccm.201907-1454OC

  • CrossRef
  • Google Scholar

• 83

  LiX.YeS.LuY. (2020). Long Non-coding RNA NEAT1 Overexpression Associates with Increased Exacerbation Risk, Severity, and Inflammation, as Well as Decreased Lung Function through the Interaction with microRNA-124 in Asthma. J. Clin. Lab. Anal.34 (1), e23023. 10.1002/jcla.23023

  • CrossRef
  • Google Scholar

• 84

  LiangY.FengY.WuW.ChangC.ChenD.ChenS.et al (2020). microRNA-218-5p Plays a Protective Role in Eosinophilic Airway Inflammation via Targeting δ-catenin, a Novel Catenin in Asthma. Clin. Exp. Allergy50 (1), 29–40. 10.1111/cea.13498

  • CrossRef
  • Google Scholar

• 85

  LiangZ.TangF. (2020). The Potency of lncRNA MALAT1/miR-155/CTLA4 axis in Altering Th1/Th2 Balance of Asthma. Biosci. Rep.40 (2), BSR20190397. 10.1042/BSR20190397

  • CrossRef
  • Google Scholar

• 86

  LinC. H.HongY. C.KaoS. H. (2015). Aeroallergen Der P 2 Induces Apoptosis of Bronchial Epithelial BEAS-2B Cells via Activation of Both Intrinsic and Extrinsic Pathway. Cell Biosci5, 71. 10.1186/s13578-015-0063-5

  • CrossRef
  • Google Scholar

• 87

  LinJ.FengX.ZhangJ. (2020). Circular RNA circHIPK3 Modulates the Proliferation of Airway Smooth Muscle Cells by miR-326/STIM1 axis. Life Sci.255, 117835. 10.1016/j.lfs.2020.117835

  • CrossRef
  • Google Scholar

• 88

  LinL.LiQ.HaoW.ZhangY.ZhaoL.HanW. (2019). Upregulation of LncRNA Malat1 Induced Proliferation and Migration of Airway Smooth Muscle Cells via miR-150-eIF4E/Akt Signaling. Front. Physiol.10, 1337. 10.3389/fphys.2019.01337

  • CrossRef
  • Google Scholar

• 89

  LiuF.QinH. B.XuB.ZhouH.ZhaoD. Y. (2012). Profiling of miRNAs in Pediatric Asthma: Upregulation of miRNA-221 and miRNA-485-3p. Mol. Med. Rep.6 (5), 1178–1182. 10.3892/mmr.2012.1030

  • CrossRef
  • Google Scholar

• 90

  LiuJ. H.LiC.ZhangC. H.ZhangZ. H. (2020). LncRNA-CASC7 Enhances Corticosteroid Sensitivity via Inhibiting the PI3K/AKT Signaling Pathway by Targeting miR-21 in Severe Asthma. Pulmonology26 (1), 18–26. 10.1016/j.pulmoe.2019.07.001

  • CrossRef
  • Google Scholar

• 91

  LiuW.LiangQ.BalzarS.WenzelS.GorskaM.AlamR. (2008). Cell-specific Activation Profile of Extracellular Signal-Regulated Kinase 1/2, Jun N-Terminal Kinase, and P38 Mitogen-Activated Protein Kinases in Asthmatic Airways. J. Allergy Clin. Immunol.121 (4), 893–e2. 10.1016/j.jaci.2008.02.004

  • CrossRef
  • Google Scholar

• 92

  LiuX.ZhangY.JiangH.JiangN.GaoJ. (2019). Integrative Analysis of the Contribution of mRNAs and Long Non-coding RNAs to the P-athogenesis of A-sthma. Mol. Med. Rep.20 (3), 2617–2624. 10.3892/mmr.2019.10511

  • CrossRef
  • Google Scholar

• 93

  LiuZ.MeiL.HeZ. (2019). Long Non-coding RNA00882 Contributes to Platelet-Derived Growth Factor-Induced Proliferation of Human Fetal Airway Smooth Muscle Cells by Enhancing Wnt/β-Catenin Signaling via Sponging miR-3619-5p. Biochem. Biophys. Res. Commun.514 (1), 9–15. 10.1016/j.bbrc.2019.04.106

  • CrossRef
  • Google Scholar

• 94

  LongC. M.LukomskaE.MarshallN. B.NayakA.AndersonS. E. (2016). Potential Inhibitory Influence of miRNA 210 on Regulatory T Cells during Epicutaneous Chemical Sensitization. Genes (Basel)8 (1), 9. 10.3390/genes8010009

  • CrossRef
  • Google Scholar

• 95

  LukiwW. J. (2013). Antagonism of NF-Κb-Up-Regulated Micro RNAs (miRNAs) in Sporadic Alzheimer's Disease (AD)-anti-NF-κB vs. Anti-miRNA Strategies. Front. Genet.4, 77. 10.3389/fgene.2013.00077

  • CrossRef
  • Google Scholar

• 96

  MalmhällC.AlawiehS.LuY.SjöstrandM.BossiosA.EldhM.et al (2014). MicroRNA-155 Is Essential for T(H)2-mediated Allergen-Induced Eosinophilic Inflammation in the Lung. J. Allergy Clin. Immunol.133 (5), 1429–1438. 10.1016/j.jaci.2013.11.008

  • CrossRef
  • Google Scholar

• 97

  MathisB. J.KusumotoM.ZaboronokA.HiramatsuY. (2021). Packaging and Delivery of Asthma Therapeutics. Pharmaceutics14 (1), 92. 10.3390/pharmaceutics14010092

  • CrossRef
  • Google Scholar

• 98

  MattesJ.CollisonA.PlankM.PhippsS.FosterP. S. (2009). Antagonism of microRNA-126 Suppresses the Effector Function of TH2 Cells and the Development of Allergic Airways Disease. Proc. Natl. Acad. Sci. U S A.106 (44), 18704–18709. 10.1073/pnas.0905063106

  • CrossRef
  • Google Scholar

• 99

  McCrackenJ. L.TrippleJ. W.CalhounW. J. (2016). Biologic Therapy in the Management of Asthma. Curr. Opin. Allergy Clin. Immunol.16 (4), 375–382. 10.1097/ACI.0000000000000284

  • CrossRef
  • Google Scholar

• 100

  MetsäläJ.LundqvistA.VirtaL. J.KailaM.GisslerM.VirtanenS. M. (2015). Prenatal and post-natal Exposure to Antibiotics and Risk of Asthma in Childhood. Clin. Exp. Allergy45 (1), 137–145. 10.1111/cea.12356

  • CrossRef
  • Google Scholar

• 101

  MidyatL.GulenF.KaracaE.OzkinayF.TanacR.DemirE.et al (2016). MicroRNA Expression Profiling in Children with Different Asthma Phenotypes. Pediatr. Pulmonol51 (6), 582–587. 10.1002/ppul.23331

  • CrossRef
  • Google Scholar

• 102

  MilagroF. I.MirandaJ.PortilloM. P.Fernandez-QuintelaA.CampiónJ.MartínezJ. A. (2013). High-throughput Sequencing of microRNAs in Peripheral Blood Mononuclear Cells: Identification of Potential Weight Loss Biomarkers. PloS one8 (1), e54319. 10.1371/journal.pone.0054319

  • CrossRef
  • Google Scholar

• 103

  MiyamotoS.HattoriN.SenooT.OnariY.IwamotoH.KaneharaM.et al (2011). Intra-airway Administration of Small Interfering RNA Targeting Plasminogen Activator Inhibitor-1 Attenuates Allergic Asthma in Mice. Am. J. Physiol. Lung Cel Mol Physiol301 (6), L908–L916. 10.1152/ajplung.00115.2011

  • CrossRef
  • Google Scholar

• 104

  MohamedJ. S.LopezM. A.BoriekA. M. (2010). Mechanical Stretch Up-Regulates microRNA-26a and Induces Human Airway Smooth Muscle Hypertrophy by Suppressing Glycogen Synthase Kinase-3β. J. Biol. Chem.285 (38), 29336–29347. 10.1074/jbc.M110.101147

  • CrossRef
  • Google Scholar

• 105

  MoralL.Asensi MonzóM.Juliá BenitoJ. C.Ortega CasanuevaC.Paniagua CalzónN. M.Pérez GarcíaM. I.et al (2021). Pediatric Asthma: The REGAP Consensus. Anales de pediatria95 (2), 125. 10.1016/j.anpede.2021.02.007

  • CrossRef
  • Google Scholar

• 106

  MukherjeeM.NairP. (2018). Autoimmune Responses in Severe Asthma. Allergy Asthma Immunol. Res.10 (5), 428–447. 10.4168/aair.2018.10.5.428

  • CrossRef
  • Google Scholar

• 107

  NarożnaB.LangwińskiW.SzczepankiewiczA. (2017). Non-Coding RNAs in Pediatric Airway Diseases. Genes8 (12), 348. 10.3390/genes8120348

  • CrossRef
  • Google Scholar

• 108

  NtontsiP.PhotiadesA.ZervasE.XanthouG.SamitasK. (2021). Genetics and Epigenetics in Asthma. Int. J. Mol. Sci.22 (5), 2412. 10.3390/ijms22052412

  • CrossRef
  • Google Scholar

• 109

  PapiA.BrightlingC.PedersenS. E.ReddelH. K. (2018). Asthma. The Lancet391 (10122), 783–800. 10.1016/s0140-6736(17)33311-1

  • CrossRef
  • Google Scholar

• 110

  PatelE. S.ChangL. J. (2012). Synergistic Effects of Interleukin-7 and Pre-T Cell Receptor Signaling in Human T Cell Development. J. Biol. Chem.287 (40), 33826–33835. 10.1074/jbc.M112.380113

  • CrossRef
  • Google Scholar

• 111

  PividoriM.SchoettlerN.NicolaeD. L.OberC.ImH. K. (2019). Shared and Distinct Genetic Risk Factors for Childhood-Onset and Adult-Onset Asthma: Genome-wide and Transcriptome-wide Studies. Lancet Respir. Med.7 (6), 509–522. 10.1016/S2213-2600(19)30055-4

  • CrossRef
  • Google Scholar

• 112

  PulidoR.LangR. (2019). Dual Specificity Phosphatases: From Molecular Mechanisms to Biological Function. Int. J. Mol. Sci.20 (18), 4372. 10.3390/ijms20184372

  • CrossRef
  • Google Scholar

• 113

  QiuL.ZhangY.DoD. C.KeX.ZhangS.LambertK.et al (2018). miR-155 Modulates Cockroach Allergen- and Oxidative Stress-Induced Cyclooxygenase-2 in Asthma. J. Immunol.201 (3), 916–929. 10.4049/jimmunol.1701167

  • CrossRef
  • Google Scholar

• 114

  QiuY. Y.WuY.LinM. J.BianT.XiaoY. L.QinC. (2019). LncRNA-MEG3 Functions as a Competing Endogenous RNA to Regulate Treg/Th17 Balance in Patients with Asthma by Targeting microRNA-17/RORγt. Biomed. Pharmacother.111, 386–394. 10.1016/j.biopha.2018.12.080

  • CrossRef
  • Google Scholar

• 115

  QiuY. Y.ZhangY. W.QianX. F.BianT. (2017). miR-371, miR-138, miR-544, miR-145, and miR-214 Could Modulate Th1/Th2 Balance in Asthma through the Combinatorial Regulation of Runx3. Am. J. Transl Res.9 (7), 3184–3199.

  • Google Scholar

• 116

  RebaneA.AkdisC. A. (2013). MicroRNAs: Essential Players in the Regulation of Inflammation. J. Allergy Clin. Immunol.132 (1), 15–26. 10.1016/j.jaci.2013.04.011

  • CrossRef
  • Google Scholar

• 117

  RundellK. W.AndersonS. D.Sue-ChuM.BougaultV.BouletL. P. (2015). Air Quality and Temperature Effects on Exercise-Induced Bronchoconstriction. Compr. Physiol.5 (2), 579–610. 10.1002/cphy.c130013

  • CrossRef
  • Google Scholar

• 118

  SaglaniS.GregoryL. G.MangheraA. K.BranchettW. J.UwadiaeF.EntwistleL. J.et al (2018). Inception of Early-Life Allergen-Induced Airway Hyperresponsiveness Is Reliant on IL-13+CD4+ T Cells. Sci. Immunol.3 (27), eaan4128. 10.1126/sciimmunol.aan4128

  • CrossRef
  • Google Scholar

• 119

  SawantD. V.WuH.KaplanM. H.DentA. L. (2013). The Bcl6 Target Gene microRNA-21 Promotes Th2 Differentiation by a T Cell Intrinsic Pathway. Mol. Immunol.54 (3-4), 435–442. 10.1016/j.molimm.2013.01.006

  • CrossRef
  • Google Scholar

• 120

  ShangY.SunY.XuJ.GeX.HuZ.XiaoJ.et al (2020). Exosomes from Mmu_circ_0001359-Modified ADSCs Attenuate Airway Remodeling by Enhancing FoxO1 Signaling-Mediated M2-like Macrophage Activation. Mol. Ther. Nucleic Acids19, 951–960. 10.1016/j.omtn.2019.10.049

  • CrossRef
  • Google Scholar

• 121

  ShiH. L.LanY. H.HuZ. C.YanZ. N.LiuZ. Z.KadierX.et al (2020). Microecology Research: a New Target for the Prevention of Asthma. Chin. Med. J. (Engl)133 (22), 2712–2720. 10.1097/CM9.0000000000001127

  • CrossRef
  • Google Scholar

• 122

  SimpsonL. J.PatelS.BhaktaN. R.ChoyD. F.BrightbillH. D.RenX.et al (2014). A microRNA Upregulated in Asthma Airway T Cells Promotes TH2 Cytokine Production. Nat. Immunol.15 (12), 1162–1170. 10.1038/ni.3026

  • CrossRef
  • Google Scholar

• 123

  SongJ.LimH. X.LeeA.KimS.LeeJ. H.KimT. S. (2019). Staphylococcus Succinus 14BME20 Prevents Allergic Airway Inflammation by Induction of Regulatory T Cells via Interleukin-10. Front. Immunol.10, 1269. 10.3389/fimmu.2019.01269

  • CrossRef
  • Google Scholar

• 124

  SouthworthT.MasonS.BellA.RamisI.CalbetM.DomenechA.et al (2018). PI3K, P38 and JAK/STAT Signalling in Bronchial Tissue from Patients with Asthma Following Allergen challenge. Biomark Res.6, 14. 10.1186/s40364-018-0128-9

  • CrossRef
  • Google Scholar

• 125

  SpecjalskiK.JassemE. (2019). MicroRNAs: Potential Biomarkers and Targets of Therapy in Allergic Diseases?Arch. Immunol. Ther. Exp. (Warsz)67 (4), 213–223. 10.1007/s00005-019-00547-4

  • CrossRef
  • Google Scholar

• 126

  SpecjalskiK.NiedoszytkoM. (2020). MicroRNAs: Future Biomarkers and Targets of Therapy in Asthma?Curr. Opin. Pulm. Med.26 (3), 285–292. 10.1097/MCP.0000000000000673

  • CrossRef
  • Google Scholar

• 127

  SripadaA.SirohiK.MichalecL.GuoL.McKayJ. T.YadavS.et al (2021). Sprouty2 Positively Regulates T Cell Function and Airway Inflammation through Regulation of CSK and LCK Kinases. Plos Biol.19 (3), e3001063. 10.1371/journal.pbio.3001063

  • CrossRef
  • Google Scholar

• 128

  SweeneyJ.BrightlingC. E.Menzies-GowA.NivenR.PattersonC. C.HeaneyL. G. (2012). Clinical Management and Outcome of Refractory Asthma in the UK from the British Thoracic Society Difficult Asthma Registry. Thorax67 (8), 754–756. 10.1136/thoraxjnl-2012-201869

  • CrossRef
  • Google Scholar

• 129

  TangH. H.TeoS. M.BelgraveD. C.EvansM. D.JacksonD. J.BrozynskaM.et al (2018). Trajectories of Childhood Immune Development and Respiratory Health Relevant to Asthma and Allergy. eLife7, e35856. 10.7554/eLife.35856

  • CrossRef
  • Google Scholar

• 130

  TangY.HuangW.SongQ.ZhengX.HeR.LiuJ. (2018). Paeonol Ameliorates Ovalbumin-Induced Asthma through the Inhibition of TLR4/NF-Κb and MAPK Signaling. Evid. Based Complement. Alternat Med.2018, 3063145. 10.1155/2018/3063145

  • CrossRef
  • Google Scholar

• 131

  TheodorouJ.NowakE.BöckA.SalvermoserM.BeerweilerC.ZeberK.et al (2022). Mitogen-activated Protein Kinase Signaling in Childhood Asthma Development and Environment-Mediated protection. Pediatr. Allergy Immunol.33 (1), e13657. 10.1111/pai.13657

  • CrossRef
  • Google Scholar

• 132

  ThomsenS. F. (2015). Genetics of Asthma: an Introduction for the Clinician. Eur. Clin. Respir. J.2. 10.3402/ecrj.v2.24643

  • CrossRef
  • Google Scholar

• 133

  TianM.ZhouY.JiaH.ZhuX.CuiY. (2018). The Clinical Significance of Changes in the Expression Levels of MicroRNA-1 and Inflammatory Factors in the Peripheral Blood of Children with Acute-Stage Asthma. Biomed. Res. Int.2018, 7632487. 10.1155/2018/7632487

  • CrossRef
  • Google Scholar

• 134

  TsitsiouE.WilliamsA. E.MoschosS. A.PatelK.RossiosC.JiangX.et al (2012). Transcriptome Analysis Shows Activation of Circulating CD8+ T Cells in Patients with Severe Asthma. J. Allergy Clin. Immunol.129 (1), 95–103. 10.1016/j.jaci.2011.08.011

  • CrossRef
  • Google Scholar

• 135

  van den BergeM.TasenaH. (2019). Role of microRNAs and Exosomes in Asthma. Curr. Opin. Pulm. Med.25 (1), 87–93. 10.1097/MCP.0000000000000532

  • CrossRef
  • Google Scholar

• 136

  WangS. Y.FanX. L.YuQ. N.DengM. X.SunY. Q.GaoW. X.et al (2017). The lncRNAs Involved in Mouse Airway Allergic Inflammation Following Induced Pluripotent Stem Cell-Mesenchymal Stem Cell Treatment. Stem Cel Res Ther8 (1), 2. 10.1186/s13287-016-0456-3

  • CrossRef
  • Google Scholar

• 137

  WangX.ChenH.LiuJ.GaiL.YanX.GuoZ.et al (2021). Emerging Advances of Non-coding RNAs and Competitive Endogenous RNA Regulatory Networks in Asthma. Bioengineered12 (1), 7820–7836. 10.1080/21655979.2021.1981796

  • CrossRef
  • Google Scholar

• 138

  WangX.XuC.CaiY.ZouX.ChaoY.YanZ.et al (2022). CircZNF652 Promotes the Goblet Cell Metaplasia by Targeting the miR-452-5p/JAK2 Signaling Pathway in Allergic Airway Epithelia. J. Allergy Clin. Immunol.S0091-6749 (22), 00129–134. 10.1016/j.jaci.2021.10.041

  • CrossRef
  • Google Scholar

• 139

  WangZ.JiN.ChenZ.WuC.SunZ.YuW.et al (2019). Next Generation Sequencing for Long Non-coding RNAs Profile for CD4+ T Cells in the Mouse Model of Acute Asthma. Front. Genet.10, 545. 10.3389/fgene.2019.00545

  • CrossRef
  • Google Scholar

• 140

  WangZ. (2010). MicroRNA: A Matter of Life or Death. World J. Biol. Chem.1 (4), 41–54. 10.4331/wjbc.v1.i4.41

  • CrossRef
  • Google Scholar

• 141

  WastiB.LiuS. K.XiangX. D. (2021). Role of Epigenetics in the Pathogenesis, Treatment, Prediction, and Cellular Transformation of Asthma. Mediators Inflamm.2021, 9412929. 10.1155/2021/9412929

  • CrossRef
  • Google Scholar

• 142

  WeidnerJ.BartelS.KılıçA.ZisslerU. M.RenzH.SchwarzeJ.et al (2021). Spotlight on microRNAs in Allergy and Asthma. Allergy76 (6), 1661–1678. 10.1111/all.14646

  • CrossRef
  • Google Scholar

• 143

  WestfallS.CaracciF.ZhaoD.WuQ.-l.FrolingerT.SimonJ.et al (2021). Microbiota Metabolites Modulate the T Helper 17 to Regulatory T Cell (Th17/Treg) Imbalance Promoting Resilience to Stress-Induced Anxiety- and Depressive-like Behaviors. Brain Behav. Immun.91, 350–368. 10.1016/j.bbi.2020.10.013

  • CrossRef
  • Google Scholar

• 144

  XiaL.WangX.LiuL.FuJ.XiaoW.LiangQ.et al (2021). lnc-BAZ2B Promotes M2 Macrophage Activation and Inflammation in Children with Asthma through Stabilizing BAZ2B Pre-mRNA. J. Allergy Clin. Immunol.147 (3), 921–e9. 10.1016/j.jaci.2020.06.034

  • CrossRef
  • Google Scholar

• 145

  XieN.LiuG. (2015). ncRNA-Regulated Immune Response and its Role in Inflammatory Lung Diseases. Am. J. Physiol. Lung Cel Mol Physiol309 (10), L1076–L1087. 10.1152/ajplung.00286.2015

  • CrossRef
  • Google Scholar

• 146

  XinY.TangL.ChenJ.ChenD.WenW.HanF. (2021). Inhibition of miR-101-3p P-rotects against S-epsis-induced M-yocardial I-njury by I-nhibiting MAPK and NF-κB P-athway A-ctivation via the U-pregulation of DUSP1. Int. J. Mol. Med.47 (3), 20. 10.3892/ijmm.2021.4853

  • CrossRef
  • Google Scholar

• 147

  XingY.WongG. W. (2022). Environmental Influences and Allergic Diseases in the Asia-Pacific Region: What Will Happen in Next 30 years?Allergy Asthma Immunol. Res.14 (1), 21–39. 10.4168/aair.2022.14.1.21

  • CrossRef
  • Google Scholar

• 148

  XuL.YiM.TanY.YiZ.ZhangY. (2020). A Comprehensive Analysis of microRNAs as Diagnostic Biomarkers for Asthma. Ther. Adv. Respir. Dis.14, 1753466620981863. 10.1177/1753466620981863

  • CrossRef
  • Google Scholar

• 149

  YangY.SunZ.RenT.LeiW. (2022). Differential Expression of lncRNA CASC2 in the Serum of Childhood Asthma and its Role in Airway Smooth Muscle Cells Proliferation and Migration. J. Asthma Allergy15, 197–207. 10.2147/JAA.S337236

  • CrossRef
  • Google Scholar

• 150

  YangY.YinX.YiJ.PengX. (2017). MiR-146a Overexpression Effectively Improves Experimental Allergic Conjunctivitis through Regulating CD4+CD25-T Cells. Biomed. Pharmacother.94, 937–943. 10.1016/j.biopha.2017.07.157

  • CrossRef
  • Google Scholar

• 151

  YoshisueH.Kirkham-BrownJ.HealyE.HolgateS. T.SampsonA. P.DaviesD. E. (2007). Cysteinyl Leukotrienes Synergize with Growth Factors to Induce Proliferation of Human Bronchial Fibroblasts. J. Allergy Clin. Immunol.119 (1), 132–140. 10.1016/j.jaci.2006.08.028

  • CrossRef
  • Google Scholar

• 152

  YuH. S.AngkasekwinaiP.ChangS. H.ChungY.DongC. (2010). Protease Allergens Induce the Expression of IL-25 via Erk and P38 MAPK Pathway. J. Korean Med. Sci.25 (6), 829–834. 10.3346/jkms.2010.25.6.829

  • CrossRef
  • Google Scholar

• 153

  ZampetakiA.WilleitP.DrozdovI.KiechlS.MayrM. (2012). Profiling of Circulating microRNAs: from Single Biomarkers to Re-wired Networks. Cardiovasc. Res.93 (4), 555–562. 10.1093/cvr/cvr266

  • CrossRef
  • Google Scholar

• 154

  ZangoueiA. S.RahimiH. R.MojarradM.MoghbeliM. (2020). Non Coding RNAs as the Critical Factors in Chemo Resistance of Bladder Tumor Cells. Diagn. Pathol.15 (1), 136. 10.1186/s13000-020-01054-3

  • CrossRef
  • Google Scholar

• 155

  ZengH.WangY.GuY.WangJ.ZhangH.GaoH.et al (2019). Polydatin Attenuates Reactive Oxygen Species-Induced Airway Remodeling by Promoting Nrf2-Mediated Antioxidant Signaling in Asthma Mouse Model. Life Sci.218, 25–30. 10.1016/j.lfs.2018.08.013

  • CrossRef
  • Google Scholar

• 156

  ZhangJ. H.YangX.ChenY. P.ZhangJ. F.LiC. Q. (2019). Nrf2 Activator RTA-408 Protects against Ozone-Induced Acute Asthma Exacerbation by Suppressing ROS and γδT17 Cells. Inflammation42 (5), 1843–1856. 10.1007/s10753-019-01046-6

  • CrossRef
  • Google Scholar

• 157

  ZhangP.WuW.ChenQ.ChenM. (2019). Non-Coding RNAs and Their Integrated Networks. J. Integr. Bioinform16 (3), 20190027. 10.1515/jib-2019-0027

  • CrossRef
  • Google Scholar

• 158

  ZhangY.SunE.LiX.ZhangM.TangZ.HeL.et al (2017). miR-155 Contributes to Df1-Induced Asthma by Increasing the Proliferative Response of Th Cells via CTLA-4 Downregulation. Cell Immunol314, 1–9. 10.1016/j.cellimm.2017.01.005

  • CrossRef
  • Google Scholar

• 159

  ZhaoX.CaiY.XuJ. (2019). Circular RNAs: Biogenesis, Mechanism, and Function in Human Cancers. Int. J. Mol. Sci.20 (16), 3926. 10.3390/ijms20163926

  • CrossRef
  • Google Scholar

• 160

  ZhouH.LiJ.GaoP.WangQ.ZhangJ. (2016). miR-155: A Novel Target in Allergic Asthma. Int. J. Mol. Sci.17 (10), 1773. 10.3390/ijms17101773

  • CrossRef
  • Google Scholar

• 161

  ZhouY.YangQ.XuH.ZhangJ.DengH.GaoH.et al (2016). miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway. PloS one11 (2), e0148821. 10.1371/journal.pone.0148821

  • CrossRef
  • Google Scholar

• 162

  ZhuX.WeiY.DongJ. (2020). Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications. Front. Pharmacol.11, 532849. 10.3389/fphar.2020.532849

  • CrossRef
  • Google Scholar

• 163

  ZhuY.MaoD.GaoW.HanG.HuH. (2019). Analysis of lncRNA Expression in Patients with Eosinophilic and Neutrophilic Asthma Focusing on LNC_000127. Front. Genet.10, 141. 10.3389/fgene.2019.00141

  • CrossRef
  • Google Scholar